OR WAIT null SECS
October 13, 2021
Rebrand launched to design, develop, and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.
October 12, 2021
PharmaLex has announced the launch of a new service line, Biopharma Excellence, and appointed a new Chief Medical Officer.
September 29, 2021
Foundational partnership enables access to novel datasets and innovation workflows through Eagle Genomics’ knowledge discovery platform.
September 14, 2021
Treatment availability for rare disease patients under fire in Europe.
August 26, 2021
Funding will be used to further develop CC Bio’s microbiome editing technologies, which harness potent enzymes derived from bacterial viruses to seek out and destroy harmful and disease-causing bacteria.
August 24, 2021
Liva Healthcare’s Philipp M. Schäfer talks about the company’s ambitions to drive a positive behavior change in type 2 diabetes.
August 13, 2021
Rory Mullen outlines Ireland’s importance to multinational pharma in the changing EU landscape.
August 10, 2021
Report claims an imbalance in influence of tech-transfer decisions.
August 09, 2021
Company strengthens end-to-end service offering with acquisitions of medical affairs and market access consultancies.
July 23, 2021
Cliodhna McDonough-Stevens looks at what the COVID-19 pandemic might mean for the future of cell and gene therapy across Europe.
